Furthermore, YB-1 regulated KLF5 expression by inhibiting DACH1 transcriptional activation or stabilizing KLF5 mRNA construction, resulting in the progression of triple-negative breast cancer (TNBC). This evidence concerns the gene KLF5 and triple-negative breast carcinoma.